Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
539.6 USD | +1.69% | +1.90% | -2.79% |
Mar. 11 | Idexx Laboratories: Superior growth prospects | |
Mar. 07 | Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing | MT |
Chart calendar IDEXX Laboratories, Inc.
Upcoming events on IDEXX Laboratories, Inc.
Past events on IDEXX Laboratories, Inc.
2024-03-04 11:00 am | Raymond James Institutional Investors Conference |
2024-02-29 10:50 am | BofA Securities Animal Health Virtual Summit |
2024-02-17 | WVC Conference |
2024-02-05 08:30 am | Q4 2023 Earnings Call |
2024-02-05 06:30 am | Q4 2023 Earnings Release |
2024-01-15 01:00 pm | Investor Meeting |
2024-01-04 01:30 pm | Goldman Sachs Healthcare C-Suite Unscripted Conference |
2023-11-01 08:30 am | Q3 2023 Earnings Call |
2023-11-01 06:30 am | Q3 2023 Earnings Release |
2023-08-10 08:00 am | Investor Day |
2023-08-01 08:30 am | Q2 2023 Earnings Call |
2023-08-01 06:30 am | Q2 2023 Earnings Release |
2023-05-31 01:15 pm | Stifel Jaws & Paws Conference |
2023-05-17 10:00 am | Annual General Meeting |
2023-05-02 08:30 am | Q1 2023 Earnings Call |
2023-05-02 06:30 am | Q1 2023 Earnings Release |
2023-03-06 10:25 am | Raymond James Institutional Investors Conference |
2023-03-02 10:00 am | BofA Securities Animal Health Summit |
2023-02-18 | WVC Conference |
2023-02-06 08:30 am | FY 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 407 2 402 0.21% | 2 707 2 661 1.72% | 3 215 3 199 0.52% | 3 367 3 355 0.37% | 3 661 3 648 0.35% | 3 991 |
EBITDA Million USD | Released Forecast Spread | 641 647 -0.93% | 791 762 3.76% | 1 037 1 035 0.16% | 1 011 1 008 0.29% | 1 212 1 210 0.17% | 1 337 |
EBIT Million USD | Released Forecast Spread | 553 554 -0.17% | 695 666 4.21% | 932 927 0.59% | 899 896 0.3% | 1 097 1 086 1.02% | 1 217 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 522 522 -0.05% | 662 632 4.76% | 903 897 0.68% | 860 859 0.1% | 1 061 1 049 1.19% | 1 180 |
Net income Million USD | Released Forecast Spread | 428 419 2.14% | 582 520 11.8% | 745 725 2.75% | 679 673 0.96% | 845 827 2.14% | 928 |
EPS USD | Released Forecast Spread | 4,89 4,77 2.44% | 6,71 6,02 11.41% | 8,60 8,39 2.53% | 8,03 7,93 1.2% | 10,1 9,85 2.09% | 11,1 |
Announcement Date | 31/01/20 | 02/02/21 | 02/02/22 | 06/02/23 | 05/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 801 782 2.46% | 837 833 0.4% | 861 862 -0.2% | 842 830 1.39% | 829 821 0.93% | 900 891 1.08% | 944 934 1.03% | 916 927 -1.27% | 902 891 1.24% | 967 | 1 027 | 1 006 | 997 | 1 063 |
EBITDA Million USD | Released Forecast Spread | 227 221 2.66% | 275 279 -1.56% | 207 206 0.47% | 282 261 7.67% | 255 248 2.78% | 309 298 3.54% | 324 303 7% | 304 292 4.1% | 275 272 1.03% | 315 | 353 | 338 | 321 | |
EBIT Million USD | Released Forecast Spread | 199 193 3.11% | 248 250 -0.53% | 179 176 1.54% | 253 233 8.37% | 227 223 1.45% | 280 271 3.57% | 296 274 7.97% | 275 267 3.18% | 245 236 3.76% | 291 | 328 | 312 | 289 | 336 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 192 186 3.44% | 241 243 -0.68% | 171 170 0.52% | 234 222 5.62% | 213 211 1.06% | 268 256 4.47% | 286 262 9.04% | 268 255 5.04% | 240 229 4.51% | 285 | 319 | 303 | 279 | 328 |
Net income Million USD | Released Forecast Spread | 163 144 12.95% | 194 192 0.86% | 132 132 -0.03% | 181 172 4.95% | 172 165 4.55% | 214 201 6.25% | 224 204 9.66% | 212 198 6.92% | 195 179 8.94% | 223 | 248 | 237 | 220 | 259 |
EPS USD | Released Forecast Spread | 1,89 1,69 11.8% | 2,27 2,24 1.38% | 1,56 1,55 0.89% | 2,15 2,04 5.54% | 2,05 1,95 5.22% | 2,55 2,38 7.05% | 2,67 2,44 9.32% | 2,53 2,37 6.66% | 2,32 2,12 9.34% | 2,66 | 2,98 | 2,85 | 2,65 | 3,12 |
Announcement Date | 02/02/22 | 04/05/22 | 02/08/22 | 01/11/22 | 06/02/23 | 02/05/23 | 01/08/23 | 01/11/23 | 05/02/24 | - | - | - | - | - |
Past sector events for IDEXX Laboratories, Inc.
2024-02-05 06:30 am | IDEXX LABORATORIES, INC.: Q4 2023 Earnings Release |
2023-11-01 06:30 am | IDEXX LABORATORIES, INC.: Q3 2023 Earnings Release |
2023-08-01 06:30 am | IDEXX LABORATORIES, INC.: Q2 2023 Earnings Release |
2023-05-02 06:30 am | IDEXX LABORATORIES, INC.: Q1 2023 Earnings Release |
2023-02-06 06:30 am | IDEXX LABORATORIES, INC.: FY 2022 Earnings Release |
2022-11-01 06:30 am | IDEXX LABORATORIES, INC.: Q3 2022 Earnings Release |
2022-08-02 06:30 am | IDEXX LABORATORIES, INC.: Interim 2022 Earnings Release |
2022-05-04 06:30 am | IDEXX LABORATORIES, INC.: Q1 2022 Earnings Release |
2022-02-02 06:30 am | IDEXX LABORATORIES, INC.: FY 2021 Earnings Release |
2021-11-02 06:30 am | IDEXX LABORATORIES, INC.: Q3 2021 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock IDEXX Laboratories, Inc. - Nasdaq
- Calendar IDEXX Laboratories, Inc.